Figure 1.
Female diffuse large B-cell lymphoma (DLBCL) patient with multifocal bone marrow involvement at baseline 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) (a), which was missed by undirected bone marrow biopsy and remitted completely after six cycles of chemoimmunotherapy (b).
